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Summary Chronic multifocal osteomyelitis (CMO) is an uncommon disease entity
with descriptions possibly emanating from the medical literature over one century
ago, and there are numerous disease entities which have been historically detailed
and which are probably synonymous. The illness is one of chronicity with exacer-
bating and remitting focal bony lesions. The differential diagnosis for a bony lesion
which ultimately proves to be CMO is initially quite broad. There is no absolute
pathognomonic clinical ﬁnding, and the diagnosis is highly dependent on clinical
course, histopathology, and an absence of microbial infection. Recent studies have
focused on immune dysfunction or dysregulation, and there are now many other
diseases which are inﬂammatory in nature and which have been diagnosed among
patients with CMO. Despite the aforementioned, the potential for direct infectious
causation or indirect causation by infectious stimulation of immunity cannot be
entirely excluded. Infection as a mechanism for pathogenesis must continue to be
entertained. Multi-centre studies are key to future research.
© 2011 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Ltd. All rights reserved.
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Table 1 Probable synonyms of chronic multifocal
osteomyelitis.
Acquired hyperostosis syndrome
Chronic multifocal cleidometaphyseal osteomyelitis
Chronic multifocal symmetrical osteomyelitis
Chronic plasmacellular osteomyelitis
Chronic recurrent multifocal osteomyelitis
Chronic sclerosing osteomyelitis
Chronic symmetric osteomyelitis
Condensing osteomyelitis
Diffuse sclerosing osteomyelitis
Intersternocostoclavicular ossiﬁcation
Lymphoplasmacellular osteomyelitis
Multifocal sterile osteomyelitis
Plasmacellular osteomyelitis
Primary chronic osteomyelitis
Primary chronic sclerosing osteomyelitis
Pustulotic arthro-osteitis
Sclerosis and hyperostosis
Sternoclavicular hyperostosis
Sternocostoclavicular hyperostosis
i
C
t
a
o
i
m
i
p
t
l
i
t
m
o
h
BIntroduction
Chronic multifocal osteomyelitis (CMO) is a difﬁ-
cult illness to diagnose for the uninitiated. While
historically a medical conundrum, there are now
considerable reports of case series. As a chronic
illness, and usually with typical infectious causes
having been ruled out, CMO is largely considered
a non-infectious disease. Is infectious causation a
moot point, or are there yet grounds to explore
microbial etiology? This paper reviews the history
and disease course of CMO and examines the pre-
vailing theories in regards to the genesis of the
illness, with special focus guided to the topic of
infection.
Historical aspects
The nature of CMO confers a low probability that
the disease is of new age. Prior to the era of diag-
nostic microbial analysis, evidently there was little
to differentiate CMO from some now recognized
infectious osteomyelitides. Most citations refer to
the radiological studies of Giedion et al. (1971)
from the Annals of Radiology to be the ﬁrst report
of CMO [1]. In retrospect, however, Garré’s descrip-
tion of 1893 should be viewed as the sentinel [2].
Many will argue that a comparison of older cita-
tions to those of current times is complicated by
the incomparable microbial techniques of the given
era.
Garré and others shortly after him provided
impetus for the term primary chronic sclerosing
osteomyelitis. Such an entity was continuing to be
underscored as recent as 1982—2001 [3—6]. In con-
temporary times, however, and with the support
of hindsight, it is likely that the historical primary
chronic sclerosing osteomyelitis was simply a uni-
focal variant of CMO, although Collert and Isacson
described patients with multifocal involvement [3].
With the current knowledge of CMO, it is credible
to also question whether differently named enti-
ties were simply variants of disease progression.
The synthesis of Suei et al. deserves our attention
g
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n this regard [4]. Given our current knowledge of
MO as detailed herein, it would not be surprising
hat unifocal episodes occur of this disease which
re never followed by a recurrence or another focus
f involvement. Perhaps the nomenclature of ‘CMO’
s overly restrictive in regards to the need to have
ore than one focus.
Of note, Giedion et al. [1] refer to ‘scleros-
ng osteomyelitis Garré’ but indicated that several
atients in their series could be differentiated from
he latter due to the presence of plasmacellu-
ar inﬁltrate in bone samples; while such inﬁltrate
n bony lesions is certainly found in many CMO,
he ﬁnding is not always made in histopathological
aterial. Of further note, Giedion et al. cite two
ther papers which detailed patients that probably
ad CMO and which preceded their article [7,8].
y the early 1980s, the entity of CMO was clearly
aining recognition [9—11].
Table 1 details many of the terminologies which
ere probably described as synonyms of CMO
4,6,12,13]. A retrospective view of reports using
Chronic multifocal osteomyelitis: Is infectious causation
Table 2 Diseases which may mimic chronic multifo-
cal osteomyelitis in their presentation.
Acute hematogenous osteomyelitis
Avascular necrosis
Chronic infectious osteomyelitis
Eosinophilic granuloma/histiocytosis
Ewing’s sarcoma
Fibrous dysplasia
Gorham’s vanishing bone disease
Hypophosphatasia
Juvenile idiopathic arthritis
Leukemia
Lymphoma
Neuroblastoma
Osteoblastoma
Osteoid osteoma
Osteosarcoma
Paget’s disease
Rhabdomyosarcoma
Rheumatoid arthritis
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review [12], citation in the Japanese medical litera-Trauma
ny of these proposed synonyms illustrates clini-
al, radiological, and other features which were
ighly similar. Table 2 details many other dis-
ase entities which may be initially confused with
MO [5,14—32]. Diagnostic procedures, especially
istopathology, among other criteria are able to
nalize the distinguishing features. One might yet
rgue that CMO is a conglomerate of causations with
commonly manifested pathology, but most would
rgue conversely that the pathogenesis is rather
niform. In this paper, the term CMO is used, but it
s conceded that several of the other terminologies
o chosen by others as detailed in Table 1 should
erhaps take precedence. A consensus is needed to
nalize the most suitable and preferred descriptor.
linical characteristics
MO is generally considered a chronic illness of
ocal bony lesions which may undergo periods of
xacerbation and remission [24,26—30]. The initial
nset may include only one bony site, although mul-
iple, sometimes symmetrical, lesions may appear
imultaneously or at variable times. For clinical
resentations of initially presumed osteomyeli-
is, CMO comprises up to 2—4% of such illnesses.
he clinical course may extend over 2—20 years
24,27,28,33,34].
The clinical presentation is usually less dra-
atic than acute hematogenous osteomyelitis, and
atients may appear to suffer very little in the way
f clinical impairment [21,22,24,26,27]. There may
t
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e complaints of mild to moderate pain localized
o a bony site. Fever occurs in less than 50% of
atients, and it is often low grade. Apart from pain
nd fever, the insidious onset may include some
egree of general malaise and localized swelling.
here may be a prolonged ﬂuctuating course
ver months to years, but symptom-free intervals
etween recurrences or the attack of alternate
ites is common. There is considerable variability
or afﬂictions of the same patient. An associated
rthritis of the nearby joint may be seen, but there
re rarely any other sequelae; premature epiphy-
eal fusion has been cited [24,26,27,29,33,35,36].
Whereas anywhere from 1 to 18 bony sites can
e involved for a given patient, the median num-
er of bony lesions is approximately 3—4. There
s a predilection for metaphyses of long bones,
lavicle, sternum, ribs, and spine, but almost any
ony site may be implicated including the jaw
14,17—21,23,24,26—28,30,37—41].
The illness is mainly one for young children and
dolescents with a median age of about ten years
5,17,19,20,22,24,27,31,34,37,39—44]. Some 10%
f patients have an onset when over the age of 20.
ecords cite patients within the ﬁrst year of life
o adults in the sixth decade of life. Females are
fﬂicted more often with the most common F/M
atio being described in patient series as 2:1, but
atios as high as 5:1 are published. The medical lit-
rature detailing CMO originates from most areas
f the world, and there is no apparent racial pre-
isposition. Of note, up to 20—40% of patients are
ecorded as having had a preceding airway infection
f some sort [22].
Two clinical entities, SAPHO syndrome and
ajeed syndrome, include CMO in the collection of
linical disease manifestations. SAPHO (Synovitis,
cne, Pustulosis, Hyperostosis, Osteitis) syndrome
ppears mainly among adults although pediatric
eries have been detailed [12,45—55]. The mus-
uloskeletal manifestations are accompanied by a
eutrophilic dermatosis which may appear as pal-
oplantar pustulosis, pustular psoriasis, or severe
lobular acne. Bones of the anterior chest wall
re commonly involved with lesser afﬂiction of the
pine or peripheral skeletal system. Joint involve-
ent appears more commonly than in CMO without
ssociated skin disease. There may be associated
acroileitis and/or spondylodiscitis. Dermatological
isease intensity often parallels bony involvement.
jorksten et al. published one of the ﬁrst case series
45], but as Kahn and Khan detail in their extensiveure seems to have occurred as early as 1967. Some
ave called SAPHO syndrome the adult presenta-
ion of CMO. In Majeed syndrome, the inﬂammatory
160
Table 3 Other disease associations with chronic mul-
tifocal osteomyelitis.
Behcet’s disease
Hypophosphatasia
IgM deﬁciency
Inﬂammatory bowel disease, especially Crohn’s
Majeed syndrome
Palmo-plantar pustulosis (SAPHO)
Polyarthritis, especially peripheral
Psoriasis
Pyoderma gangrenosum
Sacroiliitis (seronegative spondyloarthropathy)
Sweet syndrome
Takayasu’s arteritis
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dermatosis and CMO is accompanied by congenital
dyserythropoietic anemia, and the entity is recog-
nized to occur in autosomal recessive inheritance
pattern [56,57]. Majeed syndrome is quite rare hav-
ing been initially found in a consanguineous Arab
family. The disease occurs at an earlier age, has
more frequent episodes, and has short periods of
remission.
Long-term follow-up of CMO has largely proven
that most patients are unaffected by sequelae
after the last bony lesion resolves. Although it
was initially surmised that patients did not have
long-term effects, larger reviews have indicated
otherwise [28,33,44]. For example, Catalano-Pons
et al. followed a pediatric cohort in France [44].
Over 20% of children had sequelae categorized as
either physical or psychological including some that
were believed to be physical disabilities. Long-term
pain and signiﬁcant interruptions of schooling were
observed.
Among a large Toronto pediatric group, quality
of life indicators gauged impairment [28]. Long-
term problems included chronic pain. Over 75%
of patients had a lingering disease or sequelae.
An Australian review documented patients with
late physical deformities including leg length dis-
parity [33]. In another small series, complications
of thoracic outlet syndrome and progression with
Wegener’s disease were cited [58].
Ocular involvement was concomitant in a patient
[59]. One case report noted possible progression to
B cell lymphoma [60], while another report found
CMO to evolve after completing treatment for acute
lymphocytic leukemia [61].
Table 3 outlines several associa-
tions of CMO with other disease entities
[12,13,18,23,39,47,56,62—80]. Many of these
associations are inclusive of entities which would
be considered by many to be immune phenom-
i
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na. The latter speaks highly to the issues of
athogenesis and immunogenetics.
maging
hereas imaging may be useful to help distin-
uish a clinical presentation as CMO by particular
ttributes (e.g., multifocality), the radiological
resentation may not necessarily add to the other
spects of clinical presentation, and as such, the
on-speciﬁc nature of imaging appearances may
hereafter warrant a diagnostic biopsy [81]. The
omparison of infectious osteomyelitides and CMO
as been provide by Kothari et al. [82] Unique fea-
ures of imaging in CMO for particular bony sites has
lso been detailed [30]. As almost any bone may be
nvolved, lesions particularly of the clavicle (espe-
ially medial end), pelvis, spine, and facial bones
hould raise suspicion of CMO. Symmetric bony
esions should also be considered primarily as those
f CMO [82]. For spinal lesions, the appearances do
ot usually show involvement of the continguous
ertebrae, or a crossing of disc space or the ﬁnding
f soft tissue mass locally.
On routine plain radiographic examination, the
esions commonly appear as they would for classic
nfectious ostemyelitis [30]. There is an osteolytic
hange, then followed by sclerosis (as early as
—2 weeks), and hyperostosis. Early lesions may
ot have much for identiﬁcation on plain radi-
logy. Epiphyseal involvement is not often seen.
nlike chronic infectious osteomyelitis, there is no
equestrum to appreciate. Through the progression
f osteolysis, variable patterns of sclerosis emerge,
nd these are commonly resolved after some two
ears or more. Soft tissue edema, joint effusion,
nd periosteal new bone are uncommon to be seen
37]. Appearance of plain radiology may be charac-
eristic but not necessarily pathognomonic.
Technetium 99 bone scintography, or bone
canning, may be especially valuable to identify
symptomatic lesions [18]. For example, particu-
arly small areas of involvement may be difﬁcult to
ee on routine radiology. In another version, lesions
f spine and pelvis may be difﬁcult to view on
lain X-rays [37]. Bone scans may be of less value,
owever, if the bony lesion is close to an open
hysis where normal osteoblastic activity yields a
ot spot. Likewise, many deem it less desirable to
xpose children to the requisite radiation of boneRegional or whole body magnetic resonance
maging (MRI) may complement other routine radio-
raphy or bone scanning [83]. This approach will
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ihronic multifocal osteomyelitis: Is infectious caus
emonstrate medullary edema-like increased signal
ntensity along with cortical thickening, periosteal
eaction, and surrounding periosseous edema. Dur-
ng the healing processes, there is a decrease in
edullary regional intensity as ﬁbrosis and sclero-
is sets in. MRI will best outline the complexity of
one, associated joints, and nearly soft tissue. MRI
ay deﬁne abscess formation and sinus tract for-
ation which are absent in CMO. The monitoring
f a disease is better elucidated, and lesions which
re optimal for biopsy may be better deﬁned.
Imaging modalities alone or combined may show
omplications of premature epiphyseal fusion and
educed bony growth, evolutional spinal kyphosis,
nd chronic bony sclerosis.
Despite the aforementioned, and whereas there
ay be several of the ﬁndings which highly favour
MO, the distinction from acute infectious causa-
ion is not always easy.
A working strategy for radiological investigation
s proposed [30] (Fig. 1).
athology
he laboratory assessment of CMO-like lesions will
epend on the timing at which disease is encoun-
ered. Biopsy of bone for microbiological and
athological examination is more important dur-
ng the initial presentation. The latter is more
o of consequence when there is a single lesion
nd where the possibility of tumor needs to be
xcluded. Lesions in patients for whom there is a
lear pattern of recurrence and resolution, or per-
aps prior biopsy, should be of lesser laboratory
nterest.
In the very early phases of disease, more poly-
orphonuclear cells will be found in histopatho-
ogical examination. There may be osteoclastic
one resorption with the occasional giant cell.
he latter is then followed by a pattern of lym-
hocyte predominance of which some be may
lasma cells and accompanied by histiocytes and
uch fewer polymorphonuclear cells [32]. Lym-
hocytes are mainly T cells and monocytes [30].
ew bone formation may occur [84]. Late phase
xamination is more likely to show sclerotic bone,
steoid regeneration, and marrow ﬁbrosis. That
s, the initial osteolysis has then been followed
y central ﬁbrosis, metaplastic bone formation,
pposition of osteoid on pre-existing bone trabec-
lae, osteosclerosis in the periphery of the lesions,
nd periosteal ﬁbrosis [42]. Vasculitis is not seen.
bsent also largely are eosinophils (although occa-
ionally seen), granulomata (although occasionally
i
c
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een), and sequestra. Acute bacterial osteomyelitis
ore commonly demonstrates abscess formation.
Histopathology correlates well with radiological
ndings, but less often with purely clinical features
f the illness [27]. The histopathology ﬁndings in
MO are considerably variable, and some biopsies
ay show early as well as late phase changes in
he same specimen [37,42]. Nevertheless, whether
ultifocal, unifocal, recurrent, or non-recurrent,
r from SAPHO patients, the histopathology of
MO has considerable overlap with the features of
cute and subacute bacterial osteomyelitis [31].
he lack of ﬁndings for microbial growth, how-
ver completely analyzed, must also ﬁgure highly
n establishing the diagnosis. Partially treated bac-
erial osteomyelitis must be considered, and the
istory of antibiotic use prior to biopsy must be
nown.
ystemic chemistry and immunology
aboratory studies of peripheral blood are generally
ormal with few exceptions. Most studies ﬁnd ele-
ated erythrocyte sedimentation rate [18,58,85],
ut one review found largely normal values for the
ame [31]. Immunoglobulin studies tend to show no
r only non-speciﬁc elevation, e.g., up to 10% may
ave elevated IgM [18,31,58,86]. Most assessments
or HLA-B27, antinuclear antibody, and rheumatoid
actor are negative, although one report indicated
higher frequency of positive HLA-B27 compared
o the general population (21% vs. 9%) [31]. Serol-
gy for various bacterial causes is not suggestive of
nfection.
Tests for immune function are also generally nor-
al, and these have included complement levels,
eutrophil function and chemotaxis (although one
tudy suggested having found increased neutrophil
hemotaxis [85]), mitogen response, delayed-type
ypersensitivity, immune cell counts, and lympho-
yte subsets/subpopulations.
No single test or combination of tests is diagnos-
ic of CMO.
enetics
hat there should be a genetic trait which makes
eople susceptible to CMO is borne by the ﬁnd-
ngs of CMO among close relatives; these have
ncluded parental—offspring combinations, con-
ordance among monozygotic twins, and siblings
87]. Furthermore, there is a close association of
MO with inﬂammatory disorders which are more
162 N. Cimolai
plain radiography of symptomatic regions 
      + MRI if unusual complicating features 
       suspected 
bone scanning 
plain radiography of additional positive bone scan lesions 
MRI of positive bone scan lesions when plain radiography is of limited benefit 
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Adapted from [30].
becoming associated with genetic markers [27,88].
Arising from the same pattern, up to 50% of patients
with CMO have ﬁrst or second degree relatives that
suffer from some form of inﬂammatory disorder,
e.g. psoriasis.
The Majeed syndrome association with CMO,
albeit for few identiﬁed families as of yet, distinctly
has yielded ﬁndings of a gene which is mapped to
a 5.5 cM interval (1.8Mb) on chromosome 18p [78].
Mutations in this LPIN2 gene, which is apparently
found in all tissue, and expressedly so, has been
determined.
A known mouse model of CMO in mice has
found causation linked to an autosomal recessive
gene on chromosome 18 [87]. The latter obser-
vation led investigators to focus on the same
chromosome in humans, especially given that other
rare bone disorders had already been linked to
the same. Subsequent genetic molecular stud-
ies identiﬁed D18S60 as a candidate sequence,
but further work proved that the marker and
its mutations were quite different from markers
relating to other non-CMO bone disorders. The
function of D18S60 is unknown, but the ﬁnding
gives considerable credibility to the potential for
a genetic mutation/predisposition. The ﬁndings,
however, could not be conclusive to prove that
the transmission was either autosomal recessive or
dominant, with or without incomplete penetrance.
An examination of 10 patients for mutations in
the analogous gene of the CMO model mouse (PST-
PIP1 and PSTPIP2) was not rewarding [26]. Overall,
such ﬁndings may open the gateway to some
enhanced understanding of CMO causation and/or
responses.
h
o
t
mological investigation of CMO.
Human leucocyte antigen (HLA)-DR classiﬁcation
hen applied to patients with CMO does not show
ny signiﬁcant difference from the general popu-
ation [26]. Morbach et al. [89], although noting
n association with Crohn’s disease, did not ﬁnd
ARD15 gene variants.
hronic infection and the diagnostic
aradigm
MO by most current deﬁnitions includes the lack
f positive microbial diagnosis, mostly as a con-
equence of using conventional microbiological
echniques for biopsy or equivalent sample cul-
ure. In the face of a single diagnostic biopsy
hich may be acquired initially when the patient
resents with what appears to be a unifocal possi-
le osteomyelitis, negative bacteriological cultures
re generally accepted as such. There is still,
owever, considerable diversity in technique and
omplexity for standard bacteriological assess-
ent of such samples. The value of the latter
ay be limited, however, since aerobic bacteria
re mainly sought after. Multifocal osteomyeli-
is of proven infectious origin is mainly acute
nd hematogenous, albeit rare, and is caused
argely by facultative bacteria that can be found
n conventional bacteriological media whether solid
r as enrichments. There are many citations,
owever, of subacute or chronic presentations
f what proves to be multifocal osteomyelitis
hat is caused by BCG mycobacteria [90], other
ycobacteria including Mycobacterium tuberculo-
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clinical/radiological/imaging diagnosis 
bone sampling 
histopathology:    microbiology 
standard + special stains     
Gram stain 
      non-selective solid media 
      non-selective enrichment media capable 
       of supporting microaerophilic 
       and anaerobic bacteria 
sufficient material available  
      mycobacterial media, fungal media, other 
      culture media depending on clinical 
circumstances, e.g., Bartonella
negative cultures 
consider serological diagnosis depending on 
clinical circumstances, e.g., Bartonella,
fungal, Coxiella, Brucella, syphilis 
Figure 2 Diagnostic paradigm to establish or exclude diagnoses where patients with possible osteomyelitis (or poten-
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Tial CMO) are encountered.
is [91,92], Clostridium difﬁcile [93], Brucella spp.
94], Coxiella burneti [95], Pseudomonas pseudo-
allei (melioidosis) [96], Bartonella spp. [97—101],
nd fungi [102]. Citations of causation by Propi-
nibacterium acnes [6,103,104] and mycoplasmas
105] must be viewed with caution. The clinical cir-
umstances should facilitate choices for ancillary
icrobial techniques, e.g., mycobacterial culture,
.g., anaerobic culture. When the patient has
ultifocal subacute or chronic disease, greater
onsideration should be made for supplementary
iagnostic maneuvers when tissue is to be obtained.
n addition to variations or enhancements for micro-
ial culture, regard may be given to serological
tudies as many be warranted, e.g., Bartonella spp.
erology, e.g., Brucella spp. serology. The surgeon
ust be aware that generous tissue supply provides
reater diagnostic options and must also recognize
hat a generalist or specialist should be involved
n the overall clinical assessment especially for the
roader understanding of differential diagnoses.
ntibiotic pretreatment must be known since it is
apable of negating microbial culture. Specimens
cquired from chronic illnesses could in theory rep-
esent disease at a stage when viable microbe is no
onger present.
T
a
w
dGenetic detection techniques that do not depend
n the presence of viable microbe in the biopsy
pecimens have been utilized and have also been
rialed in part to determine if a non-cultivable bac-
erium might be responsible (eubacterial universal
6S rDNA ampliﬁcation [31,42]. The latter assays
ave not found bacterial genome in samples from
atients who appear to have CMO. These assess-
ents must also be accepted in the light of their
imitations since they apply to bacteria but not
o other microbes, e.g., viruses, fungi, and para-
ites. Even when applied to bacterial diagnosis, it
s unknown what sensitivity the assays may have in
iopsy specimens, although one paper claimed an
pproximate sensitivity of 20—1000 bacteria [31].
Given the above, a diagnostic paradigm is pre-
ented for consideration (Fig. 2). It must be tailored
o local practice, expectations, and exceptions.
reatmenthe use of antibiotics for CMO is generally regarded
s futile [44,106,107]. Undoubtedly many patients
ill be initiated on antibiotics shortly after a
iagnosis of osteomyelitis strongly enters into the
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differential diagnosis or after the bone samples
have been acquired and up to the time of nega-
tive bacteriological cultures. Therefore, patients
with signs of sepsis or unifocal presentation are
likely to receive antibiotics. Once the diagnosis of
CMO has been acceded to, antibiotic treatment is
reportedly of little avail. The only exception has
been the anecdotal report of azithromycin beneﬁt
[108]. Azithromycin use has not, however, received
acceptance or greater conﬁrmation as a deﬁnitive
therapy.
Most patients (>70—80%) have symptomatic ben-
eﬁt from non-steroidal anti-inﬂammatory agents
(NSAIDs) [44,106,107]. NSAID non-responders
commonly beneﬁt from corticosteroids. A wide
variety of other pharmacological agents have
been assessed in case reports or small patient
series including sulphasalazine, methotrexate,
colchicine, interferon-, interferon-, biphospho-
nates, dapsone, hyperbaric oxygen, calcitonin,
gammaglobulins, and tumor necrosis factor (TNF)-
blocking agents (e.g., inﬂiximab).
Experience with NSAIDs is considerable.
Although early review suggested little in the
way of consistency for NSAIDs [17], most have
since indicated a beneﬁt whether considerable or
modest [18,20,26,31,39,43,84,109]. NSAIDs may be
used to mitigate an illness which for many will be
short-lived and limited. NSAIDs are most beneﬁcial
for their effect on alleviating pain, but outside of
the latter, it is unclear how NSAIDs may otherwise
impact the illness. Naproxen and indomethacin use
has enjoyed success.
For NSAID non-responders or as an adjunct
in more severe illnesses, oral corticosteroids
have shown promise in about 75% of patients
[20,26,31,39,45,110]. High dose, intravenous for-
mulations may give dramatic patient response
[105]. The optimum mode, dose, and duration of
treatment are yet to be determined.
Biphosphonate pharmacological agents are
potent inhibitors of osteoclast activation thereby
in theory acting to beneﬁt CMO patients whose
lesions have evidence of bony degradation in the
midst of inﬂammation. Most reports have cited
intravenous pamidronate [20,111—113], but others
have used neridronate or zolidronic acid [114]. Dos-
ing strategies have been intermittent and tailored
to response, but optimal use of biphosphonates is
yet to be deﬁned.
TNF- inhibitors, inﬂiximab or etanercept, have
been used with some success [49,65,115]. The
larger report included two patients and a review
of previous literature [49]. In the latter review, all
patients had tried other therapies and had vari-
able success. Most patients had SAPHO associations
r
n
t
tN. Cimolai
nd were generally older than average for CMO.
f note, the TNF- inhibitors did not have an
ppreciable effect on SAPHO-associated dermati-
is. Most other immune modulating agents have
hown promise in case reports.
It is generally difﬁcult to amass reasonable series
f CMO patients for clinical trials due to the rarity
f the condition at any one medical centre. Large
ulti-centre recruitment will be essential. Surgical
reatment as a sole option has not been promoted.
The outcomes for antibiotic and non-antibiotic
reatment are perhaps suggestive that a non-
icrobial cause is operative. The lack of antibiotic
esponse, however, does not exclude viral, fungal,
arasitic, or unusual bacterial causations, nor does
he lack of antibiotic response preclude the pos-
ibility that a microbial-induced immune response
ay focus in the genesis of disease. Biphosphonate
eneﬁt too does not preclude microbial causation.
mmune or inﬂammatory modulators may have ben-
ﬁt, but microbial infection is generally associated
ith both activation of the immune response and
nduces inﬂammation.
oncepts of causation
s the body must be viewed as a miraculous
omposition of structures and functions, it is nev-
rtheless seemingly limited in expressing responses
acroscopically to a wide variety of insults. Such
imitation thereby potentially introduces consider-
ble difﬁculty at times in differentiating disease
ausation.
Infection and direct consequences — The inabil-
ty to diagnose infection through conventional
aboratory methods would seem to deﬁne CMO as
diagnosis of exclusion in part. Such an inability to
nd conventional pathogens would strongly suggest
he lack of a role for such pathogens, but it may
e on occasion, in a unifocal osteitis, that the ill-
ess is already in the course of resolution or that
rior antimicrobial treatment has already nulliﬁed
ulture attempts. Atypical, fastidious pathogens
ay not be found if microbiological culture media
re narrow in focus. Attention to ancillary culture
ethods may be dictated by clinical history. Direct
nfections may not be cultivable, and diagnosis may
nly be possible serologically.
It is more than curiosity that many CMO illnesses
rise shortly after patients suffer an upper respi-
atory infection. At this time, viral causation has
ot been entirely excluded. There is also room
o consider currently non-cultivable pathogens yet
o be deﬁned. The latter considerations would
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Rhronic multifocal osteomyelitis: Is infectious caus
e analogous to the clinician’s understanding of
artonella-related bone infections prior to the iso-
ation of Bartonella henselae and the subsequent
evelopment of related serodiagnosis.
Infection and related secondary immune
esponses — Direct cross-reactive epitopes
etween germ and bone structures have not
een studied. Lessons from rheumatic fever (i.e.,
ross-reactive heart antigens and Streptococcus
yogenes) should lead us to believe that such pos-
ibility should not be dismissed. If not an immune
esponse triggered by cross-reactivity, it is also
onceivable that infection may trigger an unrelated
ut non-speciﬁc and yet putatively disease causing
mmune reaction, e.g., Mycoplasma pneumoniae
timulating rheumatoid factor production [116]. In
ither case, where an infection-related serological
eaction may be implicated, the infection per se
oes not have to occur at the bony site. Such
echanisms of pathogenesis are yet consistent
ith culture-negative microbiological sampling.
Autoimmunity — If the disease is not trig-
ered directly by microbial infection, perhaps an
mmune dysfunction can arise when mediators of
nﬂammation trigger a genetic predisposition of
utoimmunity. For example, among those predis-
osed to lupus syndrome, it may be possible that
nfection could serve as an autoimmune trigger
fter turning on inﬂammatory or immune media-
ors and relevant but pathological immunogenetics.
nfection could serve as the latter trigger, but con-
eivably a large number of other variables/factors
ould also initiate such events. Such an explanation
or disease is consistent with the response of the
llness to immunosuppressive therapy or biological
esponse modiﬁers.
Autoinﬂammatory syndrome — A description of
his syndrome and exemplary illnesses has been
ecently outlined by Galeazzi et al. [117] They
ave deﬁned the syndrome to constitute recurrent
pisodes of systemic inﬂammation in the absence
f infection, autoantibody, or antigen speciﬁc T cell
eactivity. Labeling such an entity as a primary dys-
unction of the innate immune system, there is no
bvious trigger mechanism. Indeed, it seems to be a
athogenesis mechanism of exclusion. Perhaps this
ould be seen as an immune dysfunction yet to be
eﬁned.
Vascular or allergic processes — Although per-
aps with some overlap with the above putative
ausations, either a vascular insult to bone or an
llergic diathesis could be considered. No evidence,
owever, of vascular occlusion or vasculitis have
een found either locally or distally. Peripheral
osinophilia and IgE aberrations are unheard of as
ell.a moot point? 165
None of the above — Despite our voluminous
nowledge of microbiology, pathology, immunity,
nd genetics, it remains conceivable that the mech-
nism of disease yet to be deﬁned has little
elationship to the concepts as suggested above and
hat perhaps it is a complex of some or all of these
acets but in which the detailed evolution to CMO
s unconventional by our terms.
Although one may point to a particular disease
rocess as being likely or unlikely with the current
tate of know-how, there is yet to be determinative
tudies which can completely rule out infection as
trigger or cofactor. Given the paucity of patients
ho are diagnosed with CMO in any one medical
entre, including larger reference centres, further
tudies merit the pooling of patients and resources
rom collaborative medical sites. There is also the
ossibility that not all CMO illnesses are caused by
he same mechanism, whether infections or not.
he disease process may reﬂect a common disease
rom varied mechanisms. We may also ﬁnd that our
lustering of all such illnesses, whether unifocal or
ultifocal, is erroneous. Therefore, is the infec-
ious causation of CMO a moot point?
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